Gregory Z Ferl

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Derivation of a compartmental model for quantifying 64Cu-DOTA-RGD kinetics in tumor-bearing mice
    Gregory Z Ferl
    Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California 90095 6948, USA
    J Nucl Med 50:250-8. 2009
  2. doi request reprint Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors
    Helen Su
    Department of Molecular Medicine and Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095, USA
    Eur J Nucl Med Mol Imaging 35:1089-99. 2008
  3. pmc Estimation of the 18F-FDG input function in mice by use of dynamic small-animal PET and minimal blood sample data
    Gregory Z Ferl
    Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California 90095 6948, USA
    J Nucl Med 48:2037-45. 2007

Detail Information

Publications3

  1. pmc Derivation of a compartmental model for quantifying 64Cu-DOTA-RGD kinetics in tumor-bearing mice
    Gregory Z Ferl
    Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California 90095 6948, USA
    J Nucl Med 50:250-8. 2009
    ..To better understand the PET signal obtained with radiolabeled RGD peptides, we have constructed a compartmental model that can describe the time-activity curves in tumors after an intravenous injection...
  2. doi request reprint Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors
    Helen Su
    Department of Molecular Medicine and Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095, USA
    Eur J Nucl Med Mol Imaging 35:1089-99. 2008
    ..In this study, we asked whether PET with [(18)F]gefitinib may be used to study noninvasively the pharmacokinetics of gefitinib in vivo and to image the EGFR status of cancer cells...
  3. pmc Estimation of the 18F-FDG input function in mice by use of dynamic small-animal PET and minimal blood sample data
    Gregory Z Ferl
    Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California 90095 6948, USA
    J Nucl Med 48:2037-45. 2007
    ..We sought to develop a method for plasma time-activity curve estimation based on a model of tracer kinetics in blood, muscle, and liver...